Katharine M Wright

7PUBLICATIONS
62CO-AUTHORS
Pharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 26, 2026
The evolving role of structural biology in pharma: integration of X-ray crystallography, cryo-electron microscopy and beyond.

|Jul 10, 2024
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.

Brian J Mog, Nikita Marcou, Sarah R DiNapoli

|Jan 03, 2023
The rapid and highly parallel identification of antibodies with defined biological activities by SLISY.

Steve Lu, Austin K Mattox, P Aitana Azurmendi

|Sep 07, 2021
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens.

Michael S Hwang, Michelle S Miller, Puchong Thirawatananond

|Mar 02, 2021
TCR β chain-directed bispecific antibodies for the treatment of T cell cancers.

Suman Paul, Alexander H Pearlman, Jacqueline Douglass

|Mar 02, 2021
Targeting a neoantigen derived from a common TP53 mutation.

Emily Han-Chung Hsiue, Katharine M Wright, Jacqueline Douglass

Pageof 2

Frequent Collaborators

7 joint publications

Sandra B Gabelli

6 joint publications

Shibin Zhou

6 joint publications

Bert Vogelstein

6 joint publications

Nickolas Papadopoulos